International Clinical Trial: A Repeat Dose Study of the Dexmedetomidine Transdermal System in Healthy Subjects

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07818330) titled 'A Repeat Dose Study of the Dexmedetomidine Transdermal System in Healthy Subjects' on Sept. 7.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Teikoku Pharma USA, Inc.

Condition: Healthy Subjects

Intervention: Drug: Dexmedetomidine Transdermal System (DMTS)

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: October 30, 2026

Target Sample Size: 20

To know more, visit https://clinicaltrials.gov/study/NCT07818330

Published by HT Digital Content Services...